This report aims to provide a comprehensive presentation of the global market for Chimeric Antigen Receptor T Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chimeric Antigen Receptor T Cell Therapy. This report contains market size and forecasts of Chimeric Antigen Receptor T Cell Therapy in global, including the following market information:
Global Chimeric Antigen Receptor T Cell Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Chimeric Antigen Receptor T Cell Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Allogeneic Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Chimeric Antigen Receptor T Cell Therapy include Amgen, Bellicum Pharmaceuticals, Bluebird Bio, Caribou Biosciences, Celgene Corporation, Cellectis, Celyad Oncology, Gilead Sciences and Intellia Therapeutics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Chimeric Antigen Receptor T Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chimeric Antigen Receptor T Cell Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Chimeric Antigen Receptor T Cell Therapy Market Segment Percentages, by Type, 2022 (%)
Allogeneic
Autologous
Global Chimeric Antigen Receptor T Cell Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Chimeric Antigen Receptor T Cell Therapy Market Segment Percentages, by Application, 2022 (%)
Hospitals
Universities and Colleges
Others
Global Chimeric Antigen Receptor T Cell Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Chimeric Antigen Receptor T Cell Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chimeric Antigen Receptor T Cell Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Chimeric Antigen Receptor T Cell Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
Bellicum Pharmaceuticals
Bluebird Bio
Caribou Biosciences
Celgene Corporation
Cellectis
Celyad Oncology
Gilead Sciences
Intellia Therapeutics
Johnson & Johnson
Legend Biotech
Merck
Noile-Immune Biotech
Novartis
Pfizer
Sangamo Therapeutics
Servier Laboratories
Outline of Major Chapters:
Chapter 1: Introduces the definition of Chimeric Antigen Receptor T Cell Therapy, market overview.
Chapter 2: Global Chimeric Antigen Receptor T Cell Therapy market size in revenue.
Chapter 3: Detailed analysis of Chimeric Antigen Receptor T Cell Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Chimeric Antigen Receptor T Cell Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Chimeric Antigen Receptor T Cell Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chimeric Antigen Receptor T Cell Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chimeric Antigen Receptor T Cell Therapy Overall Market Size
2.1 Global Chimeric Antigen Receptor T Cell Therapy Market Size: 2022 VS 2029
2.2 Global Chimeric Antigen Receptor T Cell Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Chimeric Antigen Receptor T Cell Therapy Players in Global Market
3.2 Top Global Chimeric Antigen Receptor T Cell Therapy Companies Ranked by Revenue
3.3 Global Chimeric Antigen Receptor T Cell Therapy Revenue by Companies
3.4 Top 3 and Top 5 Chimeric Antigen Receptor T Cell Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Chimeric Antigen Receptor T Cell Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Chimeric Antigen Receptor T Cell Therapy Players in Global Market
3.6.1 List of Global Tier 1 Chimeric Antigen Receptor T Cell Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Chimeric Antigen Receptor T Cell Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Chimeric Antigen Receptor T Cell Therapy Market Size Markets, 2022 & 2029
4.1.2 Allogeneic
4.1.3 Autologous
4.2 By Type - Global Chimeric Antigen Receptor T Cell Therapy Revenue & Forecasts
4.2.1 By Type - Global Chimeric Antigen Receptor T Cell Therapy Revenue, 2018-2023
4.2.2 By Type - Global Chimeric Antigen Receptor T Cell Therapy Revenue, 2024-2029
4.2.3 By Type - Global Chimeric Antigen Receptor T Cell Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Chimeric Antigen Receptor T Cell Therapy Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Universities and Colleges
5.1.4 Others
5.2 By Application - Global Chimeric Antigen Receptor T Cell Therapy Revenue & Forecasts
5.2.1 By Application - Global Chimeric Antigen Receptor T Cell Therapy Revenue, 2018-2023
5.2.2 By Application - Global Chimeric Antigen Receptor T Cell Therapy Revenue, 2024-2029
5.2.3 By Application - Global Chimeric Antigen Receptor T Cell Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Chimeric Antigen Receptor T Cell Therapy Market Size, 2022 & 2029
6.2 By Region - Global Chimeric Antigen Receptor T Cell Therapy Revenue & Forecasts
6.2.1 By Region - Global Chimeric Antigen Receptor T Cell Therapy Revenue, 2018-2023
6.2.2 By Region - Global Chimeric Antigen Receptor T Cell Therapy Revenue, 2024-2029
6.2.3 By Region - Global Chimeric Antigen Receptor T Cell Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Chimeric Antigen Receptor T Cell Therapy Revenue, 2018-2029
6.3.2 US Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.3.3 Canada Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.3.4 Mexico Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Chimeric Antigen Receptor T Cell Therapy Revenue, 2018-2029
6.4.2 Germany Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.4.3 France Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.4.4 U.K. Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.4.5 Italy Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.4.6 Russia Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.4.8 Benelux Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Chimeric Antigen Receptor T Cell Therapy Revenue, 2018-2029
6.5.2 China Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.5.3 Japan Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.5.4 South Korea Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.5.6 India Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Chimeric Antigen Receptor T Cell Therapy Revenue, 2018-2029
6.6.2 Brazil Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.6.3 Argentina Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Revenue, 2018-2029
6.7.2 Turkey Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.7.3 Israel Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.7.5 UAE Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
7 Chimeric Antigen Receptor T Cell Therapy Companies Profiles
7.1 Amgen
7.1.1 Amgen Company Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Chimeric Antigen Receptor T Cell Therapy Major Product Offerings
7.1.4 Amgen Chimeric Antigen Receptor T Cell Therapy Revenue in Global Market (2018-2023)
7.1.5 Amgen Key News & Latest Developments
7.2 Bellicum Pharmaceuticals
7.2.1 Bellicum Pharmaceuticals Company Summary
7.2.2 Bellicum Pharmaceuticals Business Overview
7.2.3 Bellicum Pharmaceuticals Chimeric Antigen Receptor T Cell Therapy Major Product Offerings
7.2.4 Bellicum Pharmaceuticals Chimeric Antigen Receptor T Cell Therapy Revenue in Global Market (2018-2023)
7.2.5 Bellicum Pharmaceuticals Key News & Latest Developments
7.3 Bluebird Bio
7.3.1 Bluebird Bio Company Summary
7.3.2 Bluebird Bio Business Overview
7.3.3 Bluebird Bio Chimeric Antigen Receptor T Cell Therapy Major Product Offerings
7.3.4 Bluebird Bio Chimeric Antigen Receptor T Cell Therapy Revenue in Global Market (2018-2023)
7.3.5 Bluebird Bio Key News & Latest Developments
7.4 Caribou Biosciences
7.4.1 Caribou Biosciences Company Summary
7.4.2 Caribou Biosciences Business Overview
7.4.3 Caribou Biosciences Chimeric Antigen Receptor T Cell Therapy Major Product Offerings
7.4.4 Caribou Biosciences Chimeric Antigen Receptor T Cell Therapy Revenue in Global Market (2018-2023)
7.4.5 Caribou Biosciences Key News & Latest Developments
7.5 Celgene Corporation
7.5.1 Celgene Corporation Company Summary
7.5.2 Celgene Corporation Business Overview
7.5.3 Celgene Corporation Chimeric Antigen Receptor T Cell Therapy Major Product Offerings
7.5.4 Celgene Corporation Chimeric Antigen Receptor T Cell Therapy Revenue in Global Market (2018-2023)
7.5.5 Celgene Corporation Key News & Latest Developments
7.6 Cellectis
7.6.1 Cellectis Company Summary
7.6.2 Cellectis Business Overview
7.6.3 Cellectis Chimeric Antigen Receptor T Cell Therapy Major Product Offerings
7.6.4 Cellectis Chimeric Antigen Receptor T Cell Therapy Revenue in Global Market (2018-2023)
7.6.5 Cellectis Key News & Latest Developments
7.7 Celyad Oncology
7.7.1 Celyad Oncology Company Summary
7.7.2 Celyad Oncology Business Overview
7.7.3 Celyad Oncology Chimeric Antigen Receptor T Cell Therapy Major Product Offerings
7.7.4 Celyad Oncology Chimeric Antigen Receptor T Cell Therapy Revenue in Global Market (2018-2023)
7.7.5 Celyad Oncology Key News & Latest Developments
7.8 Gilead Sciences
7.8.1 Gilead Sciences Company Summary
7.8.2 Gilead Sciences Business Overview
7.8.3 Gilead Sciences Chimeric Antigen Receptor T Cell Therapy Major Product Offerings
7.8.4 Gilead Sciences Chimeric Antigen Receptor T Cell Therapy Revenue in Global Market (2018-2023)
7.8.5 Gilead Sciences Key News & Latest Developments
7.9 Intellia Therapeutics
7.9.1 Intellia Therapeutics Company Summary
7.9.2 Intellia Therapeutics Business Overview
7.9.3 Intellia Therapeutics Chimeric Antigen Receptor T Cell Therapy Major Product Offerings
7.9.4 Intellia Therapeutics Chimeric Antigen Receptor T Cell Therapy Revenue in Global Market (2018-2023)
7.9.5 Intellia Therapeutics Key News & Latest Developments
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Company Summary
7.10.2 Johnson & Johnson Business Overview
7.10.3 Johnson & Johnson Chimeric Antigen Receptor T Cell Therapy Major Product Offerings
7.10.4 Johnson & Johnson Chimeric Antigen Receptor T Cell Therapy Revenue in Global Market (2018-2023)
7.10.5 Johnson & Johnson Key News & Latest Developments
7.11 Legend Biotech
7.11.1 Legend Biotech Company Summary
7.11.2 Legend Biotech Business Overview
7.11.3 Legend Biotech Chimeric Antigen Receptor T Cell Therapy Major Product Offerings
7.11.4 Legend Biotech Chimeric Antigen Receptor T Cell Therapy Revenue in Global Market (2018-2023)
7.11.5 Legend Biotech Key News & Latest Developments
7.12 Merck
7.12.1 Merck Company Summary
7.12.2 Merck Business Overview
7.12.3 Merck Chimeric Antigen Receptor T Cell Therapy Major Product Offerings
7.12.4 Merck Chimeric Antigen Receptor T Cell Therapy Revenue in Global Market (2018-2023)
7.12.5 Merck Key News & Latest Developments
7.13 Noile-Immune Biotech
7.13.1 Noile-Immune Biotech Company Summary
7.13.2 Noile-Immune Biotech Business Overview
7.13.3 Noile-Immune Biotech Chimeric Antigen Receptor T Cell Therapy Major Product Offerings
7.13.4 Noile-Immune Biotech Chimeric Antigen Receptor T Cell Therapy Revenue in Global Market (2018-2023)
7.13.5 Noile-Immune Biotech Key News & Latest Developments
7.14 Novartis
7.14.1 Novartis Company Summary
7.14.2 Novartis Business Overview
7.14.3 Novartis Chimeric Antigen Receptor T Cell Therapy Major Product Offerings
7.14.4 Novartis Chimeric Antigen Receptor T Cell Therapy Revenue in Global Market (2018-2023)
7.14.5 Novartis Key News & Latest Developments
7.15 Pfizer
7.15.1 Pfizer Company Summary
7.15.2 Pfizer Business Overview
7.15.3 Pfizer Chimeric Antigen Receptor T Cell Therapy Major Product Offerings
7.15.4 Pfizer Chimeric Antigen Receptor T Cell Therapy Revenue in Global Market (2018-2023)
7.15.5 Pfizer Key News & Latest Developments
7.16 Sangamo Therapeutics
7.16.1 Sangamo Therapeutics Company Summary
7.16.2 Sangamo Therapeutics Business Overview
7.16.3 Sangamo Therapeutics Chimeric Antigen Receptor T Cell Therapy Major Product Offerings
7.16.4 Sangamo Therapeutics Chimeric Antigen Receptor T Cell Therapy Revenue in Global Market (2018-2023)
7.16.5 Sangamo Therapeutics Key News & Latest Developments
7.17 Servier Laboratories
7.17.1 Servier Laboratories Company Summary
7.17.2 Servier Laboratories Business Overview
7.17.3 Servier Laboratories Chimeric Antigen Receptor T Cell Therapy Major Product Offerings
7.17.4 Servier Laboratories Chimeric Antigen Receptor T Cell Therapy Revenue in Global Market (2018-2023)
7.17.5 Servier Laboratories Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Chimeric Antigen Receptor T Cell Therapy Market Opportunities & Trends in Global Market
Table 2. Chimeric Antigen Receptor T Cell Therapy Market Drivers in Global Market
Table 3. Chimeric Antigen Receptor T Cell Therapy Market Restraints in Global Market
Table 4. Key Players of Chimeric Antigen Receptor T Cell Therapy in Global Market
Table 5. Top Chimeric Antigen Receptor T Cell Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Chimeric Antigen Receptor T Cell Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Chimeric Antigen Receptor T Cell Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Chimeric Antigen Receptor T Cell Therapy Product Type
Table 9. List of Global Tier 1 Chimeric Antigen Receptor T Cell Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chimeric Antigen Receptor T Cell Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Chimeric Antigen Receptor T Cell Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Chimeric Antigen Receptor T Cell Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Chimeric Antigen Receptor T Cell Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Chimeric Antigen Receptor T Cell Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 30. Amgen Company Summary
Table 31. Amgen Chimeric Antigen Receptor T Cell Therapy Product Offerings
Table 32. Amgen Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Amgen Key News & Latest Developments
Table 34. Bellicum Pharmaceuticals Company Summary
Table 35. Bellicum Pharmaceuticals Chimeric Antigen Receptor T Cell Therapy Product Offerings
Table 36. Bellicum Pharmaceuticals Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Bellicum Pharmaceuticals Key News & Latest Developments
Table 38. Bluebird Bio Company Summary
Table 39. Bluebird Bio Chimeric Antigen Receptor T Cell Therapy Product Offerings
Table 40. Bluebird Bio Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Bluebird Bio Key News & Latest Developments
Table 42. Caribou Biosciences Company Summary
Table 43. Caribou Biosciences Chimeric Antigen Receptor T Cell Therapy Product Offerings
Table 44. Caribou Biosciences Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Caribou Biosciences Key News & Latest Developments
Table 46. Celgene Corporation Company Summary
Table 47. Celgene Corporation Chimeric Antigen Receptor T Cell Therapy Product Offerings
Table 48. Celgene Corporation Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Celgene Corporation Key News & Latest Developments
Table 50. Cellectis Company Summary
Table 51. Cellectis Chimeric Antigen Receptor T Cell Therapy Product Offerings
Table 52. Cellectis Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Cellectis Key News & Latest Developments
Table 54. Celyad Oncology Company Summary
Table 55. Celyad Oncology Chimeric Antigen Receptor T Cell Therapy Product Offerings
Table 56. Celyad Oncology Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Celyad Oncology Key News & Latest Developments
Table 58. Gilead Sciences Company Summary
Table 59. Gilead Sciences Chimeric Antigen Receptor T Cell Therapy Product Offerings
Table 60. Gilead Sciences Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Gilead Sciences Key News & Latest Developments
Table 62. Intellia Therapeutics Company Summary
Table 63. Intellia Therapeutics Chimeric Antigen Receptor T Cell Therapy Product Offerings
Table 64. Intellia Therapeutics Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Intellia Therapeutics Key News & Latest Developments
Table 66. Johnson & Johnson Company Summary
Table 67. Johnson & Johnson Chimeric Antigen Receptor T Cell Therapy Product Offerings
Table 68. Johnson & Johnson Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Johnson & Johnson Key News & Latest Developments
Table 70. Legend Biotech Company Summary
Table 71. Legend Biotech Chimeric Antigen Receptor T Cell Therapy Product Offerings
Table 72. Legend Biotech Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. Legend Biotech Key News & Latest Developments
Table 74. Merck Company Summary
Table 75. Merck Chimeric Antigen Receptor T Cell Therapy Product Offerings
Table 76. Merck Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 77. Merck Key News & Latest Developments
Table 78. Noile-Immune Biotech Company Summary
Table 79. Noile-Immune Biotech Chimeric Antigen Receptor T Cell Therapy Product Offerings
Table 80. Noile-Immune Biotech Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 81. Noile-Immune Biotech Key News & Latest Developments
Table 82. Novartis Company Summary
Table 83. Novartis Chimeric Antigen Receptor T Cell Therapy Product Offerings
Table 84. Novartis Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 85. Novartis Key News & Latest Developments
Table 86. Pfizer Company Summary
Table 87. Pfizer Chimeric Antigen Receptor T Cell Therapy Product Offerings
Table 88. Pfizer Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 89. Pfizer Key News & Latest Developments
Table 90. Sangamo Therapeutics Company Summary
Table 91. Sangamo Therapeutics Chimeric Antigen Receptor T Cell Therapy Product Offerings
Table 92. Sangamo Therapeutics Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 93. Sangamo Therapeutics Key News & Latest Developments
Table 94. Servier Laboratories Company Summary
Table 95. Servier Laboratories Chimeric Antigen Receptor T Cell Therapy Product Offerings
Table 96. Servier Laboratories Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 97. Servier Laboratories Key News & Latest Developments
List of Figures
Figure 1. Chimeric Antigen Receptor T Cell Therapy Segment by Type in 2022
Figure 2. Chimeric Antigen Receptor T Cell Therapy Segment by Application in 2022
Figure 3. Global Chimeric Antigen Receptor T Cell Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Chimeric Antigen Receptor T Cell Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Chimeric Antigen Receptor T Cell Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Chimeric Antigen Receptor T Cell Therapy Revenue in 2022
Figure 8. By Type - Global Chimeric Antigen Receptor T Cell Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Chimeric Antigen Receptor T Cell Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Chimeric Antigen Receptor T Cell Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Chimeric Antigen Receptor T Cell Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Chimeric Antigen Receptor T Cell Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Chimeric Antigen Receptor T Cell Therapy Revenue Market Share, 2018-2029
Figure 16. US Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Chimeric Antigen Receptor T Cell Therapy Revenue Market Share, 2018-2029
Figure 20. Germany Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Chimeric Antigen Receptor T Cell Therapy Revenue Market Share, 2018-2029
Figure 28. China Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Chimeric Antigen Receptor T Cell Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. Amgen Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bellicum Pharmaceuticals Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bluebird Bio Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Caribou Biosciences Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Celgene Corporation Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Cellectis Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Celyad Oncology Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Gilead Sciences Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Intellia Therapeutics Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Johnson & Johnson Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Legend Biotech Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Merck Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Noile-Immune Biotech Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Novartis Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Pfizer Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Sangamo Therapeutics Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Servier Laboratories Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
